Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-035364
Date:2021-05-20
Issuer: PMV PHARMACEUTICALS, INC. (PMVP)
Original Submission Date:

Reporting Person:

MACK DAVID HENRY
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3 CRANBURY, NJ 08512

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-20 M 7,793 a $0.53 10,263 direct
COMMON STOCK 2021-05-20 S 7,793 d $35.60 2,470 direct
COMMON STOCK 2021-05-21 M 6,207 a $0.53 8,677 direct
COMMON STOCK 2021-05-21 S 6,207 d $35.71 2,470 direct
COMMON STOCK 2021-05-20 0 $0.00 227,915 indirect f4
COMMON STOCK 2021-05-20 0 $0.00 56,978 indirect f5
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.53 2021-05-20 deemed execution date M 7,793 (d) 2025-05-11 common stock 7,793 $0.53 492,867 direct
STOCK OPTION (RIGHT TO BUY) 0.53 2021-05-21 deemed execution date M 6,207 (d) 2025-05-11 common stock 6,207 $0.53 485,074 direct
Footnotes
IDfootnote
f1 the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 29, 2020.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this form 4.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive.
f4 the shares are held of record by the mack-mulligan revocable trust, for which the reporting person serves as co-trustee.
f5 the shares are held of record by the mack/mulligan 2020 irrevocable descendants' trust, for which the reporting person serves as co-trustee.
f6 the shares subject to the option are fully vested and immediately exercisable.

Elevate your investments